Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.
about
Drug-Induced Metabolic AcidosisTenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?HIV and kidney diseases: 35 years of history and consequencesA Review of Management of Inflammation in the HIV PopulationRisk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral TreatmentTenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicityTenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transportersIncomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureDrug-induced impairment of renal function.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Association of urine α1-microglobulin with kidney function decline and mortality in HIV-infected womenSwitching tenofovir/emtricitabine plus lopinavir/r to raltegravir plus Darunavir/r in patients with suppressed viral load did not result in improvement of renal function but could sustain viral suppression: a randomized multicenter trialPredictors of resolution and persistence of renal laboratory abnormalities in pediatric HIV infectionA consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection.Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trialNephrotoxicity of HAARTKrüppel-like factor 6 regulates mitochondrial function in the kidneyAcute kidney injury in patients with human immunodeficiency virus infection.Renal Function Recovery and HIV Viral Suppression Following Tenofovir Discontinuation for Renal Impairment.Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series.Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases.Impact of nucleos(t)ide analogue combination therapy on the estimated glomerular filtration rate in patients with chronic hepatitis BSafety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention.Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis.Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir.Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV.Renal dysfunction among HIV-infected patients starting antiretroviral therapy.Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.Kidney disease in children and adolescents with perinatal HIV-1 infection.Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir.Association of tenofovir exposure with kidney disease risk in HIV infection.Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection.BMS-986001, an HIV nucleoside reverse transcriptase inhibitor, does not degrade mitochondrial DNA in long-term primary cultures of cells isolated from human kidney, muscle, and adipose tissue.Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis.Delayed onset renal failure in a patient on tenofovir based antiretroviral regimen.Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature.Recent advances in the treatment of chronic hepatitis B.Renal toxicity associated with antiretroviral therapy.Update on tenofovir toxicity in the kidney.Drug-induced renal Fanconi syndrome.
P2860
Q26766204-561730AB-8E14-46CA-82D4-F8247576D6F8Q26995852-7E888FE8-00FF-4838-9540-E6C113D38C68Q28069641-6C3FA12B-5762-44E8-971F-8DA9A1589A86Q28078962-85442FBA-828F-465E-9391-73A1547505C2Q28554081-F9DE345B-B6C6-48E7-B21F-5E9648938434Q33551834-5B7C28E6-8EBD-4447-A5A7-7726873BFF6EQ33845879-365E68F5-09E2-4401-AF34-992450A69DCCQ33880241-831404F3-7259-48BB-9058-7CD371ECB560Q34731462-2AEF9120-9A84-44BA-BB9E-344ED4B424BDQ34736194-DAFAC6CC-A0C6-41EC-953E-274B6EED54E4Q34828514-E89DB0E8-262C-43AE-9439-B152CADC33E5Q34952127-3EDC9BB0-3251-4C81-845C-CA9E174E32C0Q34993406-C7E99028-9C15-4793-99A6-B15EF11C9526Q35149475-56660354-A0AC-4420-96F4-F4A087A834FBQ35163040-086D65AC-867B-4459-ABDF-5F064B38B4EBQ35167944-ABFCA9ED-AAC3-4483-8FE5-6C9E1996626AQ35183941-E1297087-112F-430D-8E95-93A1605C9F3FQ35232997-C440A755-616E-488D-8E9A-2B0E038A3995Q35748339-41E70814-5E08-4776-ABA8-E3D8360B3F2CQ35891568-7149E502-ADC6-4CA2-B5FA-FD3966E4B01EQ36067839-87F38A61-7D7D-4E41-A6F6-806AA538CABBQ36151245-631BC0A4-DB3C-4B33-B845-322681652DD8Q36586078-E206A401-74F1-49B4-8E70-11B254C08B38Q36629910-D6A329D2-5192-4CCD-88E8-8B387950F8B6Q36651106-2CA8B824-33F1-46B9-A66C-2EB692F4F534Q36663586-0FEDCE20-92B5-4A8A-9520-698B587F9DE6Q36781012-BA4018AF-7148-4CE4-BB77-DC181F110069Q36910943-7167A7DD-E73A-4915-87E9-925067FCD2CFQ36942310-5BCEBD03-4617-4875-9ABC-3F53D948AA47Q36988748-A27D6900-50B2-485E-991D-BD970838CA96Q37077982-70744977-DF32-48F7-91AB-0BCC5E08B1C7Q37238911-778ED46F-1BCE-4625-9945-93EADE857F64Q37335637-52275D9C-3B15-4199-9968-9E4F1A60197CQ37665912-65136CA4-95C1-4BA7-BC0C-C2471C57C3BEQ37703573-853EA677-650A-4F47-AA9B-9EF4F4F49060Q37874616-EBD8D7C8-6634-4C99-9C6C-1C71ADF4BA9DQ37891094-D6E1EFA5-6547-4F26-9A18-95D59E9224EDQ38031028-503F8BDF-D2A9-4488-BD20-641017659834Q38033446-956B6A77-AB59-4913-BDC7-6D7B75A589D8Q38173853-950D4829-B739-4420-A5E7-8A3EB1136EF7
P2860
Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tenofovir nephrotoxicity: acut ...... d mitochondrial abnormalities.
@ast
Tenofovir nephrotoxicity: acut ...... d mitochondrial abnormalities.
@en
Tenofovir nephrotoxicity: acut ...... d mitochondrial abnormalities.
@nl
type
label
Tenofovir nephrotoxicity: acut ...... d mitochondrial abnormalities.
@ast
Tenofovir nephrotoxicity: acut ...... d mitochondrial abnormalities.
@en
Tenofovir nephrotoxicity: acut ...... d mitochondrial abnormalities.
@nl
prefLabel
Tenofovir nephrotoxicity: acut ...... d mitochondrial abnormalities.
@ast
Tenofovir nephrotoxicity: acut ...... d mitochondrial abnormalities.
@en
Tenofovir nephrotoxicity: acut ...... d mitochondrial abnormalities.
@nl
P2093
P50
P356
P1433
P1476
Tenofovir nephrotoxicity: acut ...... nd mitochondrial abnormalities
@en
P2093
Glen S Markowitz
Jai Radhakrishnan
Vivette D D'Agati
P2888
P304
P356
10.1038/KI.2010.318
P407
P577
2010-09-01T00:00:00Z
P5875
P6179
1013776476